HCR 76

  • Louisiana House Concurrent Resolution
  • 2022 Regular Session
  • Introduced in House
  • Passed House May 03, 2022
  • Passed Senate May 23, 2022
  • Governor

HEALTH/SICKLE CELL ANEM: Expresses support for equitable access to transformative therapies for sickle cell disease

Abstract

Bill Sponsors (45)

Joseph Bouie

     
Cosponsor

Votes


Actions


May 26, 2022

House

Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.

May 25, 2022

Senate

Signed by the President of the Senate.

May 24, 2022

House

Enrolled and signed by the Speaker of the House.

May 23, 2022

House

Received from the Senate without amendments.

Senate

Read by title and concurred in by a vote of 37 yeas and 0 nays. Ordered returned to the House.

May 18, 2022

Senate

Reported favorably.

May 09, 2022

Senate

Read second time by title and referred to the Committee on Health and Welfare.

May 04, 2022

Senate

Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

May 03, 2022

House

Read by title, roll called on final consideration, yeas 93, nays 0. The resolution was adopted and ordered to the Senate.

House

Called from the calendar.

House

Read by title, returned to the calendar.

Apr 28, 2022

House

Scheduled for floor debate on 05/03/2022.

House

Read by title, ordered engrossed, passed to 3rd reading.

Apr 27, 2022

House

Reported favorably (10-1).

Apr 21, 2022

House

Read by title, under the rules, referred to the Committee on Health and Welfare.

Apr 20, 2022

House

Read by title. Lies over under the rules.

Bill Text

Bill Text Versions Format
HCR76 Enrolled PDF
HCR76 Engrossed PDF
HCR76 Original PDF

Related Documents

Document Format
Digest of HCR76 Original PDF
Digest of HCR76 Engrossed PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Louisiana Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.